160 related articles for article (PubMed ID: 32648979)
1. Productivity costs associated with metastatic breast cancer in younger, midlife, and older women.
Trogdon JG; Liu X; Reeder-Hayes KE; Rotter J; Ekwueme DU; Wheeler SB
Cancer; 2020 Sep; 126(18):4118-4125. PubMed ID: 32648979
[TBL] [Abstract][Full Text] [Related]
2. Productivity Costs Associated With Breast Cancer Among Survivors Aged 18-44 Years.
Ekwueme DU; Trogdon JG; Khavjou OA; Guy GP
Am J Prev Med; 2016 Feb; 50(2):286-94. PubMed ID: 26775908
[TBL] [Abstract][Full Text] [Related]
3. Projecting the Prevalence and Costs of Metastatic Breast Cancer From 2015 through 2030.
Gogate A; Wheeler SB; Reeder-Hayes KE; Ekwueme DU; Fairley TL; Drier S; Trogdon JG
JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34409255
[TBL] [Abstract][Full Text] [Related]
4. Medical costs associated with metastatic breast cancer in younger, midlife, and older women.
Trogdon JG; Baggett CD; Gogate A; Reeder-Hayes KE; Rotter J; Zhou X; Ekwueme DU; Fairley TL; Wheeler SB
Breast Cancer Res Treat; 2020 Jun; 181(3):653-665. PubMed ID: 32346820
[TBL] [Abstract][Full Text] [Related]
5. Years of potential life lost and productivity costs due to premature mortality from six priority diseases in Tanzania, 2006-2015.
Rumisha SF; George J; Bwana VM; Mboera LEG
PLoS One; 2020; 15(6):e0234300. PubMed ID: 32516340
[TBL] [Abstract][Full Text] [Related]
6. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003.
Ekwueme DU; Chesson HW; Zhang KB; Balamurugan A
Cancer; 2008 Nov; 113(10 Suppl):2936-45. PubMed ID: 18980277
[TBL] [Abstract][Full Text] [Related]
7. Productivity costs of cancer mortality in the United States: 2000-2020.
Bradley CJ; Yabroff KR; Dahman B; Feuer EJ; Mariotto A; Brown ML
J Natl Cancer Inst; 2008 Dec; 100(24):1763-70. PubMed ID: 19066273
[TBL] [Abstract][Full Text] [Related]
8. Health and economic impact of breast cancer mortality in young women, 1970-2008.
Ekwueme DU; Guy GP; Rim SH; White A; Hall IJ; Fairley TL; Dean HD
Am J Prev Med; 2014 Jan; 46(1):71-9. PubMed ID: 24355674
[TBL] [Abstract][Full Text] [Related]
9. Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
Sorensen SV; Goh JW; Pan F; Chen C; Yardley D; Martín M; Knopf K; Benedict A; Giorgetti C; Iyer S
Int J Technol Assess Health Care; 2012 Jan; 28(1):12-21. PubMed ID: 22617734
[TBL] [Abstract][Full Text] [Related]
10. Years of potential life lost and productivity losses from male urogenital cancer deaths--United States, 2004.
Li C; Ekwueme DU; Rim SH; Tangka FK
Urology; 2010 Sep; 76(3):528-35. PubMed ID: 20573389
[TBL] [Abstract][Full Text] [Related]
11. Years of potential life lost and productivity costs due to premature cancer-related mortality in Iran.
Khorasani S; Rezaei S; Rashidian H; Daroudi R
Asian Pac J Cancer Prev; 2015; 16(5):1845-50. PubMed ID: 25773835
[TBL] [Abstract][Full Text] [Related]
12. The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden.
Hanly PA; Sharp L
BMC Cancer; 2014 Mar; 14():224. PubMed ID: 24670067
[TBL] [Abstract][Full Text] [Related]
13. The economic impact of cancer mortality among working-age individuals in Brazil from 2001 to 2030.
De Camargo Cancela M; Monteiro Dos Santos JE; Lopes de Souza LB; Martins LFL; Bezerra de Souza DL; Barchuk A; Hanly P; Sharp L; Soerjomataram I; Pearce A
Cancer Epidemiol; 2023 Oct; 86():102438. PubMed ID: 37579673
[TBL] [Abstract][Full Text] [Related]
14. Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe.
Hanly P; Soerjomataram I; Sharp L
Int J Cancer; 2015 Feb; 136(4):E136-45. PubMed ID: 25066804
[TBL] [Abstract][Full Text] [Related]
15. Indirect costs associated with metastatic breast cancer.
Wan Y; Gao X; Mehta S; Wang Z; Faria C; Schwartzberg L
J Med Econ; 2013 Oct; 16(10):1169-78. PubMed ID: 23866016
[TBL] [Abstract][Full Text] [Related]
16. Years of potential life lost and valued years of potential life lost in assessing premature mortality in Slovenia.
Semerl JS; Sesok J
Croat Med J; 2002 Aug; 43(4):439-45. PubMed ID: 12187522
[TBL] [Abstract][Full Text] [Related]
17. Years of potential life lost and productivity costs due to COVID-19 in Turkey: one yearly evaluation.
Gökler ME; Metintaş S
Public Health; 2022 Feb; 203():91-96. PubMed ID: 35033739
[TBL] [Abstract][Full Text] [Related]
18. Productivity-adjusted life years lost due to type 2 diabetes in Germany in 2020 and 2040.
Tönnies T; Hoyer A; Brinks R
Diabetologia; 2021 Jun; 64(6):1288-1297. PubMed ID: 33665686
[TBL] [Abstract][Full Text] [Related]
19. Metastatic breast cancer in young women: a population-based cohort study to describe risk and prognosis.
Tjokrowidjaja A; Lee CK; Houssami N; Lord S
Intern Med J; 2014 Aug; 44(8):764-70. PubMed ID: 24863750
[TBL] [Abstract][Full Text] [Related]
20. Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018.
Ortega-Ortega M; Hanly P; Pearce A; Soerjomataram I; Sharp L
Int J Cancer; 2022 Feb; 150(4):580-593. PubMed ID: 34569617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
